[1
]
From the Minneapolis Veterans Affairs (VA) Health Care System and Center for Chronic
Disease Outcomes Research and the Section of General Medicine, University of Minnesota
School of Medicine, Minneapolis (T.J.W.); the VA Cooperative Studies Program Coordinating
Center, Perry Point, MD (K.M.J.); the General Medicine Division, Massachusetts General
Hospital, Boston (M.J.B.); the Division of Urology, Washington University School of
Medicine, St. Louis (G.L.A.); the Department of Urology, University of Oklahoma College
of Medicine, Oklahoma City (D.C.); the Department of Pathology and Immunology, Baylor
College of Medicine, Houston (T.W.); VA Medical Center, Greater Los Angeles Healthcare
System, Los Angeles (W.J.A.); and Myriad Genetics Laboratories, Salt Lake City (M.K.B.).